Xi Chen
The placebo effect and its determinants in fibromyalgia: meta-analysis of randomized controlled trials
Chen, Xi; Zou, Kun; Abdullah, Natasya; Whiteside, Nicola; Sarmanova, Aliya; Doherty, Michael; Zhang, Weiya
Authors
Kun Zou
Natasya Abdullah
Nicola Whiteside
Aliya Sarmanova
Michael Doherty
Professor WEIYA ZHANG WEIYA.ZHANG@NOTTINGHAM.AC.UK
PROFESSOR OF EPIDEMIOLOGY
Abstract
The aims of this study were to determine whether placebo treatment in randomised controlled trials (RCTs) is effective for fibromyalgia and to identify possible determinants of the magnitude of any such placebo effect. A systematic literature search was undertaken for RCTs in people with fibromyalgia that included a placebo and/or a no-treatment (observation only or waiting list) control group. Placebo effect size (ES) for pain and other outcomes was measured as the improvement of each outcome from baseline divided by the standard deviation of the change from baseline. This effect was compared with changes in the no-treatment control groups. Meta-analysis was undertaken to combine data from different studies. Subgroup analysis was conducted to identify possible determinants of the placebo ES. A total of 3912 studies were identified from the literature search. After scrutiny, 229 trials met the inclusion criteria. Participants who received placebo in the RCTs experienced significantly better improvements in pain, fatigue, sleep quality, physical function, and other main outcomes than those receiving no treatment. The ES of placebo for pain relief was clinically moderate (0.53, 95%CI 0.48 to 0.57). The ES increased with increasing strength of the active treatment, increasing participant age and higher baseline pain severity, but decreased in RCTS with more women and with longer duration of fibromyalgia. In addition, placebo treatment in RCTs is effective in fibromyalgia. A number of factors (expected strength of treatment, age, gender, disease duration) appear to influence the magnitude of the placebo effect in this condition.
Citation
Chen, X., Zou, K., Abdullah, N., Whiteside, N., Sarmanova, A., Doherty, M., & Zhang, W. (in press). The placebo effect and its determinants in fibromyalgia: meta-analysis of randomized controlled trials. Clinical Rheumatology, https://doi.org/10.1007/s10067-017-3595-8
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 7, 2017 |
Online Publication Date | Mar 15, 2017 |
Deposit Date | Mar 9, 2017 |
Publicly Available Date | Mar 15, 2017 |
Journal | Clinical Rheumatology |
Print ISSN | 0770-3198 |
Electronic ISSN | 1434-9949 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s10067-017-3595-8 |
Keywords | Fibromyalgia, Meta-analysis, Pain management, Placebo effect, Rheumatic diseases, Systematic reviews and methodology |
Public URL | https://nottingham-repository.worktribe.com/output/850290 |
Publisher URL | https://link.springer.com/article/10.1007%2Fs10067-017-3595-8 |
Contract Date | Mar 9, 2017 |
Files
Placebo art%3A10.1007%2Fs10067-017-3595-8.pdf
(569 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Association Between Hyperuricemia and Ultrasound-Detected Hand Synovitis
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search